Recent Analyst Forecasts and Stock Ratings
Halozyme Therapeutics, Inc. FAQ's
Halozyme Therapeutics, Inc. has been rated by research analysts at UBS, Goldman Sachs, JMP Securities, Morgan Stanley, Leerink Partners, H.C. Wainwright in the past 90 days.